SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFS14A - Definitive proxy statement for special meeting:
SEC Accession No. 0000950133-97-000748
Filing Date
1997-03-10
Accepted
1997-03-10 00:00:00
Documents
1
Period of Report
1997-04-01
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 NOTICE AND PROXY STATEMENT DEFS14A 27195
  Complete submission text file 0000950133-97-000748.txt   28541
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFS14A | Act: 34 | File No.: 000-23736 | Film No.: 97553608
SIC: 2834 Pharmaceutical Preparations